International

Harris, Trump neck to neck in new poll

Darpan News Desk , 24 Jul, 2024 12:24 PM

Washington, July 24 (IANS) According to a latest poll, the race between Ex President Donald Trump and Vice President Kamala Harris is at razor's edge in the aftermath of President Biden’s decision to drop out.

Trump got support of 49% of voters while Harris had the backing of 47% of the voters.

A defining goal of my presidency will be to build up the middle class.

When the middle class is strong, America is strong.
— Kamala Harris (@KamalaHarris) July 24, 2024

The news was not great for Harris among young voters, with Trump having the backing of 58% of those in the 18-34 age bracket. Harris, on the other hand, just had 39% of support an astounding 19 point lead for Trump.

Harris will now be gearing up for the Democratic National Convention next month before she takes on Trump in the 2024 election in November.

Prev Next

MORE International ARTICLES

WHO: 'Premature,' 'unrealistic' COVID-19 will end soon

The world’s singular focus right now should be to keep transmission of COVID-19 as low as possible, said Dr. Michael Ryan, director of WHO's emergencies program.

WHO: 'Premature,' 'unrealistic' COVID-19 will end soon

New coronavirus variant in New York spurs caution, concern

One of the spike protein mutations is seen in the variants discovered early on in Brazil and South Africa, and, now, the new variant in New York.

New coronavirus variant in New York spurs caution, concern

White House on U.S. vaccine supply: America first

That's despite the challenges faced by other countries, including Canada, in procuring vaccine doses from outside the United States.

White House on U.S. vaccine supply: America first

Attacks on older Asians stoke fear as Lunar New Year begins

City officials also have visited Chinatowns in San Francisco and Oakland this week to address residents' safety concerns and condemn the violence.

Attacks on older Asians stoke fear as Lunar New Year begins

UN: 'Concerning news' vaccines may not work against variants

Tedros added that WHO expected to make a decision “in the next few days” on whether it would recommend an emergency use listing for the AstraZeneca vaccine.